Status: Recruiting
MMA Embolization for Refractory Chronic Migraine
This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.
Participants needed: 70
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Cerenovus, Part of DePuy Synthes Products, Inc.Updated: Jun 8, 2026Locations: 9
Eligibility criteria
Patient is between 18 and 65 years of age (inclusive) at the time of consent [+4]
Patients with a history for the last 2 years of other primary headache types, or... [+4]